Vijay B. Samant's Insider Trades & SAST Disclosures
Vijay B. Samant's most recent trade in Fresh Tracks Therapeutics Inc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 17, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vijay B. Samant.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2021 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Grant, award, or other acquisition of securities at price $ 0.81 per share. | 15 Sep 2020 | 10,493 | 23,542 (0%) | 0% | 0.8 | 8,499 | Common Stock |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 6,375 | 13,049 (0%) | 0% | 0.9 | 5,993 | Common Stock |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 609 | 0 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2020 | 609 | 19,680 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.94 per share. | 31 Aug 2020 | 256 | 19,424 (0%) | 0% | 0.9 | 241 | Common Stock |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 608 | 19,327 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2020 | 608 | 609 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.92 per share. | 31 Jul 2020 | 256 | 19,071 (0%) | 0% | 0.9 | 236 | Common Stock |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 608 | 1,217 | - | - | Restricted Stock Units | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2020 | 608 | 18,975 (0%) | 0% | - | Common Stock | |
| Fresh Tracks Therapeutics Inc | Vijay B. Samant | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.00 per share. | 30 Jun 2020 | 256 | 18,719 (0%) | 0% | 1 | 256 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges